{"id":"https://openalex.org/W4362482698","doi":"https://doi.org/10.1158/1535-7163.22509588","title":"Supplemental Table 1 from Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma","display_name":"Supplemental Table 1 from Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362482698","doi":"https://doi.org/10.1158/1535-7163.22509588"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22509588","doi":"https://doi.org/10.1158/1535-7163.22509588","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509588","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Co-targeting_HGF_cMET_Signaling_with_MEK_Inhibitors_in_Metastatic_Uveal_Melanoma/22509588/1/files/39971472.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Co-targeting_HGF_cMET_Signaling_with_MEK_Inhibitors_in_Metastatic_Uveal_Melanoma/22509588/1/files/39971472.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087595506","display_name":"Hanyin Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanyin Cheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055634444","display_name":"Vivian Y.L. Chua","orcid":"https://orcid.org/0000-0002-1873-6820","observed_orcids":["https://orcid.org/0000-0002-1873-6820"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Chua","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060883368","display_name":"Connie Liao","orcid":"https://orcid.org/0009-0006-2846-9638","observed_orcids":["https://orcid.org/0009-0006-2846-9638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Connie Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085398803","display_name":"Timothy J. Purwin","orcid":"https://orcid.org/0000-0002-7053-8039","observed_orcids":["https://orcid.org/0000-0002-7053-8039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy J. Purwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036217332","display_name":"Mizue Terai","orcid":"https://orcid.org/0000-0003-2672-9468","observed_orcids":["https://orcid.org/0000-0003-2672-9468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mizue Terai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030422981","display_name":"Ken Kageyama","orcid":"https://orcid.org/0000-0002-0787-9789","observed_orcids":["https://orcid.org/0000-0002-0787-9789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Kageyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053828591","display_name":"Takami Sato","orcid":"https://orcid.org/0000-0003-2221-0415","observed_orcids":["https://orcid.org/0000-0003-2221-0415"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takami Sato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/metastatic-uveal-melanoma","display_name":"metastatic uveal melanoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/treatment-history","display_name":"treatment history","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.658685564994812},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.6242991089820862},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6008927822113037},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5442339777946472},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4609855115413666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44441336393356323},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4110247492790222},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1162930428981781},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22509588","doi":"https://doi.org/10.1158/1535-7163.22509588","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509588","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Co-targeting_HGF_cMET_Signaling_with_MEK_Inhibitors_in_Metastatic_Uveal_Melanoma/22509588/1/files/39971472.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22509588.v1","doi":"https://doi.org/10.1158/1535-7163.22509588.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509588.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22509588","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Co-targeting_HGF_cMET_Signaling_with_MEK_Inhibitors_in_Metastatic_Uveal_Melanoma/22509588","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22509588","doi":"https://doi.org/10.1158/1535-7163.22509588","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509588","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Co-targeting_HGF_cMET_Signaling_with_MEK_Inhibitors_in_Metastatic_Uveal_Melanoma/22509588/1/files/39971472.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362482698.pdf","grobid_xml":"https://content.openalex.org/works/W4362482698.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362567820","https://openalex.org/W2582283428","https://openalex.org/W939929027","https://openalex.org/W2504266415","https://openalex.org/W3208917129","https://openalex.org/W835444613","https://openalex.org/W3134215187","https://openalex.org/W2150915626","https://openalex.org/W4392687471","https://openalex.org/W7098267238"],"abstract_inverted_index":{"Supplemental":[0],"Table":[1],"1:":[2],"Patient":[3],"characteristics":[4],"and":[5],"treatment":[6],"history.":[7]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-04-05T00:00:00"}